A Sojourn, Ultane, Sevorane CEP of the European Pharmacopoeia monograph is often referred to as a Sojourn, Ultane, Sevorane Certificate of Suitability (COS). The purpose of a Sojourn, Ultane, Sevorane CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sojourn, Ultane, Sevorane EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sojourn, Ultane, Sevorane to their clients by showing that a Sojourn, Ultane, Sevorane CEP has been issued for it. The manufacturer submits a Sojourn, Ultane, Sevorane CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sojourn, Ultane, Sevorane CEP holder for the record. Additionally, the data presented in the Sojourn, Ultane, Sevorane CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sojourn, Ultane, Sevorane DMF.
A Sojourn, Ultane, Sevorane CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sojourn, Ultane, Sevorane CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Sojourn, Ultane, Sevorane suppliers with CEP (COS) on PharmaCompass.